ArticleBMJ case reports2014

Uncommon side effect with a commonly used targeted agent: sunitinib-induced nephrotic syndrome in a patient with metastatic renal cell carcinoma.

Keith Ian Quintyne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.